Jon S. Saxe - Mar 4, 2024 Form 4 Insider Report for Vistagen Therapeutics, Inc. (VTGN)

Role
Director
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
Mar 4, 2024
Transactions value $
$0
Form type
4
Date filed
3/6/2024, 06:00 PM
Previous filing
Mar 3, 2022
Next filing
Sep 10, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTGN Stock Option (Right to Buy) Award $0 +12.5K $0.00 12.5K Mar 4, 2024 Common Stock 12.5K $4.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant.